Status: current, Sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom clinical extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2887921000000112 | Allergy to alirocumab | en | Synonym | Active | Entire term case insensitive | SNOMED CT United Kingdom clinical extension module |
| 2887931000000114 | Allergy to alirocumab (finding) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT United Kingdom clinical extension module |
| 2887941000000117 | Alirocumab allergy | en | Synonym | Active | Entire term case insensitive | SNOMED CT United Kingdom clinical extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Allergy to alirocumab | Is a | Allergy to proprotein convertase subtilisin/kexin type 9 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Allergy to alirocumab | Causative agent | Alirocumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Allergy to alirocumab | Has realization | Allergic process | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR